Liver fibrosis -- from bench to bedside.

By S. Friedman. Journal of Hepatology, 2003

1,810 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/dd7296d30e456fa0165872828233694a0afdfc22

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. J. Bonner
2. Robert D. Goldin
3. Ralf Weiskirchen
4. A. Gressner
5. Q. Anstee

In Hepatology

1. J. Bonner
2. Robert D. Goldin
3. Ralf Weiskirchen
4. A. Gressner
5. Q. Anstee
6. S. Friedman

Citations in the corpus

• Regulation of PDGF and its receptors in fibrotic diseases. (2004, background): “Liver cirrhosis is the end stage consequence of fibrosis of the hepatic parenchyma, yet reversal of cirrhosis is often possible [59].”
• Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets (2006, background): “Under certain conditions reversibility of fibrosis can be reached [6, 99–101].”
• Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research (2006, background): “It is widely accepted that TGFb has an important regulatory role in the development of liver fibrosis (Friedman 2003).”